Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 187 citing Vijan: Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. (0.09 sec) 

Development and progression of nephropathy in type 2 diabetes: the United …


AI Adler, RJ Stevens, SE Manley, RW Bilous, CA Cull, … - Kidney international, 2003 - nature.com
The progression of nephropathy from diagnosis of type 2 diabetes has not been well described from a
single population. This study sought to describe the development and progression through the stages
of microalbuminuria, ...
Cited by 388 - Related articles - BL Direct - All 4 versions

Screening for type 2 diabetes.

- diabetesjournals.org [PDF] 
MM Engelgau, KM Narayan, WH Herman - Diabetes Care, 2000 - Am Diabetes Assoc
In 1997, nearly 16 million people in the US had diabetes (1,2). Of this population, 10.3 million
were diag- nosed and 5.4 million were undiagnosed (1,2). In the future, these numbers are expected
to increase substantially (3). Type ...
Cited by 222 - Related articles - All 9 versions

Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice …

- annals.org
S Vijan, RA Hayward - Annals of internal medicine, 2003 - Am Coll Physicians
Background: Hypertension in patients with type 2 diabetes mellitus is a prevalent condition that
leads to substantial morbidity and mortality. ... Purpose: To evaluate the goals and optimal agents
for treatment of hypertension in ...
Cited by 188 - Related articles - BL Direct - All 11 versions

The diabetes quality improvement project

- Free from Publisher
BB Fleming, S Greenfield, MM Engelgau, LM … - Diabetes Care, 2001 - Am Diabetes Assoc
As the worldwide diabetes epidemic continues to unfold, some experts have asked whether the war
against it is being lost (1,2,3). In the US, blindness, kidney failure, amputations, and
cardiovascular disease resulting ...
Cited by 165 - Related articles - BL Direct - All 6 versions

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with …

- rushakoff.com [PDF] 
S Vijan, TP Hofer, RA Hayward - Jama, 2000 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web standards. Find out
more about why this message is appearing and what you can do to make your experience on this site
better.
Cited by 159 - Related articles - BL Direct - All 5 versions

Systematic review: comparative effectiveness and safety of oral medications for …


S Bolen, L Feldman, J Vassy, L Wilson, HC … - Annals of Internal …, 2007 - Am Coll Physicians
Purpose: To summarize the English-language literature on the benefits and harms of oral agents
(second-generation sulfonylureas, biguanides, thiazolidinediones, meglitinides, and α-glucosidase
inhibitors) in the treatment of ...
Cited by 152 - Related articles - BL Direct - All 12 versions

Diabetes in elderly adults

- washington.edu [PDF] 
GS Meneilly, D Tessier - … of Gerontology Series A: Biological and …, 2001 - Geron Soc America
Diabetes is common in the elderly population. By the age of 75, approximately 20% of the population
are afflicted with this illness. Diabetes in elderly adults is metabolically distinct from diabetes
in younger patient populations, and ...
Cited by 108 - Related articles - BL Direct - All 6 versions

Narrative review: lack of evidence for recommended low-density lipoprotein …


RA Hayward, TP Hofer, S Vijan - Annals of internal medicine, 2006 - Am Coll Physicians
Recent national recommendations have proposed that physicians should titrate lipid therapy to
achieve low-density lipoprotein (LDL) cholesterol levels less than 1.81 mmol/L (<70 mg/dL) for
patients at very high ...
Cited by 99 - Related articles - BL Direct - All 6 versions

Archimedes


DM Eddy, L Schlessinger - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—The model includes the pertinent organ systems, more than 50 continuously interacting
biological variables, and the major symptoms, tests, treatments, and outcomes. The level of detail
corresponds to that found in ...
Cited by 98 - Related articles - BL Direct - All 5 versions

[PDF] Avoiding pitfalls in chronic disease quality measurement: a case for the next …


EA Kerr, SL Krein, S Vijan, TP Hofer, RA … - American Journal of …, 2001 - ajmc.com
Eve A. Kerr, MD, MPH; Sarah L. Krein, PhD, RN; Sandeep Vijan, MD, MS; Timothy P. Hofer, MD, MS; and
Rodney A. Hayward, MD ... Current Efforts to Measure the Quality of Healthcare In 1997, the
President's Advisory Commission on ...
Cited by 92 - Related articles - View as HTML - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google